Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
| ▸ | LOX | P28300 | 1/20 | 0.30 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.30 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.30 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.30 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.30 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.30 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.30 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4620956 | 0.98 | NPC1 (0.36) | NPC1HPGDOPRM1FFAR4KCNA5 | |
| SCHEMBL7295826 | 0.95 | NPC1 (0.32) | NPC1FFAR4 | |
| SCHEMBL7306025 | 0.91 | HSD17B3 (0.31) | — | |
| SCHEMBL7323836 | 0.90 | NPC1 (0.35) | NPC1HPGDFFAR4SCN5AHRH3 | |
| SCHEMBL7307584 | 0.90 | OPRM1 (0.41) | NPC1OPRM1SCN5AOPRK1OPRD1 | |
| SCHEMBL7295050 | 0.88 | FFAR4 (0.33) | NPC1HPGDFFAR4HRH3 | |
| SCHEMBL7304224 | 0.88 | OPRM1 (0.42) | NPC1OPRM1SCN5AOPRK1OPRD1 | |
| SCHEMBL7337609 | 0.85 | HRH3 (0.39) | NPC1HPGDOPRM1SCN5AOPRK1 | |
| SCHEMBL7304360 | 0.85 | FFAR4 (0.33) | FFAR4HRH3 | |
| SCHEMBL7306774 | 0.84 | OPRM1 (0.39) | OPRM1SCN5AOPRK1OPRD1HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2894685-B1 | BENZOTHIENOBENZOTHIOPHENE DERIVATIVE, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC TRANSISTOR | DAINIPPON INK & CHEMICALS (JP) | 2018-10-31 | — | — | EP | disclosed |
| US-20180248131-A1 | ORGANIC COMPOUND, METHOD FOR PREPARING SAME, ORGANIC SEMICONDUCTOR MATERIAL CONTAINING SAME, AND ORGANIC TRANSISTOR CONTAINING SAME | DIC CORPORATION (JP) | 2018-08-30 | — | — | US | disclosed |
| EP-3342769-A1 | ORGANIC COMPOUND, METHOD FOR MANUFACTURING SAME, ORGANIC SEMICONDUCTOR MATERIAL CONTAINING SAME, AND ORGANIC TRANSISTOR CONTAINING SAME | DIC Corporation (JP) | 2018-07-04 | — | — | EP | disclosed |
| CN-107207458-A | Organic compound, its manufacture method, the organic semiconducting materials containing it and the organic transistor containing it | DIC株式会社 | 2017-09-26 | — | — | CN | disclosed |
| CN-104769735-B | Benzothiophene and benzothiophene derivative, organic semiconducting materials and organic transistor | DIC株式会社 | 2017-07-28 | — | — | CN | disclosed |
| US-9490433-B2 | Benzothienobenzothiophene derivative, organic semiconductor material, and organic transistor | DIC CORPORATION (JP) | 2016-11-08 | — | — | US | disclosed |
| US-20150228913-A1 | BENZOTHIENOBENZOTHIOPHENE DERIVATIVE, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC TRANSISTOR | DIC CORPORATION (JP) | 2015-08-13 | — | — | US | disclosed |
| EP-2894685-A1 | BENZOTHIENOBENZOTHIOPHENE DERIVATIVE, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC TRANSISTOR | DIC Corporation (JP) | 2015-07-15 | — | — | EP | disclosed |
| CN-104769735-A | Benzothienobenzothiophene derivative, organic semiconductor material, and organic transistor | CENTRE NAT RECH SCIENT | 2015-07-08 | — | — | CN | disclosed |
| US-5135932-A | 2-HYDROXYPROPYLAMINO-ALKYL-BENZIMIDAZOLY-5-YL DERIVATIVES AND THEIR USE IN THE TREATMENT OF HEART DISEASE | DR. KARL THOMAE GMBH (DE) | 1992-08-04 | — | — | US | disclosed |
| EP-0400519-A1 | 2-Hydroxy-n-propylamines, medicaments containing these compounds and method for preparing them | Dr. Karl Thomae GmbH (DE) | 1990-12-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180248131-A1 | ORGANIC COMPOUND, METHOD FOR PREPARING SAME, ORGANIC SEMICONDUCTOR MATERIAL CONTAINING SAME, AND ORGANIC TRANSISTOR CONTAINING SAME | TST, SOAT1, SOAT2 | NPC1 2274/4885HPGD 1880/4885OPRM1 3926/4885 |
| US-20150228913-A1 | BENZOTHIENOBENZOTHIOPHENE DERIVATIVE, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC TRANSISTOR | TST, TPST2, TPR | NPC1 1230/4885HPGD 3780/4885OPRM1 3310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.